2011 Radiotherapy Today and Tomorrow

  • December 2011
  • -
  • Frost & Sullivan

This study looks at emerging trends in the radiosurgery market and the residual impact of the financial crisis from both a market and an end-user hospital perspective. Stereotactic Radiosurgery (SRS) is an advanced form of radiotherapy capable of synchronizing tumor detection, surgical guidance, and radiation delivery components in a manner that can treat localized tumors. SRS systems, due to their accuracy and precision, minimize damage to healthy tissue, making them ideal for treatment of complicated tumors located near the brain or spine. This survey is intended to gather qualitative feedback on how radiosurgery centers plan to work around external challenges.

Table Of Contents

2011 Radiotherapy Today and Tomorrow
Table of Contents

Market Overview and Metrics 4
Case Study: Gamma Knife Surgery Program Perceptions 24
About Frost and Sullivan 45


View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • January 2015
  • by Global Data

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. ...

Radiotherapy: Technologies and Global Markets

Radiotherapy: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • February 2015
  • by BCC Research

REPORT HIGHLIGHTS The radiation therapy market totaled $5.4 billion in 2013 and $5.8 billion in 2014. The market is expected to reach $8.1 billion in 2019, a compound annual growth rate(CAGR) of 6.7%. ...

Therapeutics for ”Silent” Cancers

Therapeutics for ”Silent” Cancers

  • $ 6 650
  • Industry report
  • February 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014. This market is expected to reach almost $13.6 billion by 2019, with a compound annual ...

Biomarker - World Panorama

March 2015 $ 3 750

Oncology - World Panorama

May 2015 $ 3 750

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.